These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30641612)

  • 1. [Memory Clinics in Germany - Results of a Hospital Survey].
    Meiberth D; Rapp MA; Jessen F
    Psychiatr Prax; 2019 May; 46(4):213-216. PubMed ID: 30641612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany.
    Bartels C; Kögel A; Schweda M; Wiltfang J; Pentzek M; Schicktanz S; Schneider A
    J Alzheimers Dis; 2020; 78(3):1137-1148. PubMed ID: 33104034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Memory clinics in Germany-structural requirements and areas of responsibility].
    Hausner L; Frölich L; von Arnim CAF; Bohlken J; Dodel R; Otto M; Rapp M; Schulz J; Supprian T; Wollmer MA; Jessen F;
    Nervenarzt; 2021 Jul; 92(7):708-715. PubMed ID: 33025072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics].
    Onur OA; Wolff-Menzler C; von Arnim CAF; Jessen F; Fink GR; Wiltfang J; Laske C; Schneider A; Levin J; Oberstein T; Kornhuber J; Oberhauser F; Gallinat J; Dodel R; Otto M; Peters O; Teipel S; Duezel E; Riemenschneider M; Flöel A; Perneczky R; Reetz K; Schulz JB; Hausner L; Grimmer T; Frölich L
    Fortschr Neurol Psychiatr; 2022 Jul; 90(7-08):361-367. PubMed ID: 35858613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informant Questionnaires in Dedicated Memory Clinics: How Much Do They Contribute?
    Novak L; Wyss P; Lenouvel E; Abdulkadir A; Klöppel S
    J Am Geriatr Soc; 2021 Jan; 69(1):106-113. PubMed ID: 32936455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From mild cognitive impairment to dementia: what is the role of public health?].
    Vanacore N; Di Pucchio A; Lacorte E; Bacigalupo I; Mayer F; Grande G; Cesari M; Canevelli M
    Recenti Prog Med; 2017 May; 108(5):211-215. PubMed ID: 28643811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Everyday Activities Across the Dementia Spectrum with the Amsterdam IADL Questionnaire.
    Facal D; Carabias MAR; Pereiro AX; Lojo-Seoane C; Campos-Magdaleno M; Jutten RJ; Sikkes SAM; Juncos-Rabadán O
    Curr Alzheimer Res; 2018; 15(13):1261-1266. PubMed ID: 30251604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia].
    Bürge M; Bieri G; Brühlmeier M; Colombo F; Demonet JF; Felbecker A; Georgescu D; Gietl A; Brioschi Guevara A; Jüngling F; Kirsch E; Kressig RW; Kulic L; Monsch AU; Ott M; Pihan H; Popp J; Rampa L; Rüegger-Frey B; Schneitter M; Unschuld PG; von Gunten A; Weinheimer B; Wiest R; Savaskan E
    Praxis (Bern 1994); 2018 Apr; 107(8):435-451. PubMed ID: 29642795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study.
    Bruun M; Frederiksen KS; Rhodius-Meester HFM; Baroni M; Gjerum L; Koikkalainen J; Urhemaa T; Tolonen A; van Gils M; Tong T; Guerrero R; Rueckert D; Dyremose N; Andersen BB; Simonsen AH; Lemstra A; Hallikainen M; Kurl S; Herukka SK; Remes AM; Waldemar G; Soininen H; Mecocci P; van der Flier WM; Lötjönen J; Hasselbalch SG
    Curr Alzheimer Res; 2019; 16(2):91-101. PubMed ID: 30605060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Neurol; 2019 Mar; 266(3):745-754. PubMed ID: 30635723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of Coded Prodromal Mild Cognitive Impairment in the Routine Treatment of Patients with Dementia in Germany.
    Bohlken J; Kostev K
    J Alzheimers Dis; 2018; 65(2):393-399. PubMed ID: 30056428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How valid are subjective ratings of prospective memory in mild cognitive impairment and early dementia?
    Thompson CL; Henry JD; Rendell PG; Withall A; Brodaty H
    Gerontology; 2015; 61(3):251-7. PubMed ID: 25792282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden.
    Sheikh F; Ismail Z; Mortby ME; Barber P; Cieslak A; Fischer K; Granger R; Hogan DB; Mackie A; Maxwell CJ; Menon B; Mueller P; Patry D; Pearson D; Quickfall J; Sajobi T; Tse E; Wang M; Smith EE;
    Int Psychogeriatr; 2018 Feb; 30(2):233-244. PubMed ID: 28879833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation and Validation of the Memory Alteration Test (M@T) in Greek Middle-Aged, Older, and Older-Old Population with Subjective Cognitive Decline and Mild Cognitive Impairment.
    Lazarou I; Moraitou D; Papatheodorou M; Vavouras I; Lokantidou C; Agogiatou C; Gialaoutzis M; Nikolopoulos S; Stavropoulos TG; Kompatsiaris I; Tsolaki M
    J Alzheimers Dis; 2021; 84(3):1219-1232. PubMed ID: 34657882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in People with Mild Cognitive Impairment.
    Mallo SC; Ismail Z; Pereiro AX; Facal D; Lojo-Seoane C; Campos-Magdaleno M; Juncos-Rabadán O
    J Alzheimers Dis; 2018; 66(1):83-95. PubMed ID: 30175974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.
    Schweda M; Kögel A; Bartels C; Wiltfang J; Schneider A; Schicktanz S
    J Alzheimers Dis; 2018; 62(1):145-155. PubMed ID: 29439325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of consultation organizations in the early detection of dementia: from the practices of the Community Consultation Center for Citizens with Mild Cognitive Impairment and Dementia, Nippon Medical School.
    Nomura T; Matsumoto S; Kitamura S; Ishiwata A; Ishii C; Nemoto R; Kawanami O
    J Nippon Med Sch; 2012; 79(6):438-43. PubMed ID: 23291842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MemClin project: a prospective multi memory clinics study targeting early stages of cognitive impairment.
    Ekman U; Ferreira D; Muehlboeck JS; Wallert J; Rennie A; Eriksdotter M; Wahlund LO; Westman E
    BMC Geriatr; 2020 Mar; 20(1):93. PubMed ID: 32138686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.